# Quantum Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quantum-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Montpellier, France
- Website: www.quantumsurgical.com
- Total disclosed funding: $6.8M
- Latest round: Series A (Aug 13, 2018)
- Investors on record: 2

## About

Quantum Surgical SAS focuses on innovative, minimally invasive solutions for cancer treatment, enhancing the precision and effectiveness of tumor ablation through the advanced Epione® robotic platform.Founded in 2017 and headquartered in Montpellier, France, Quantum Surgical SAS specializes in the development of robotic systems for cancer treatments. The company has raised a total of EUR 5.00 mn in funding, with the most recent funding round occurring on March 27, 2024, where it secured EUR 5.00 mn. The company was co-founded by Bertin Nahum and Lucien Blondel, with Bertin Nahum serving as the CEO. Quantum Surgical has completed a total of 4 deals to date, emphasizing its growth and strategic initiatives in the healthcare sector.Quantum Surgical specializes in minimally invasive cancer treatment solutions, primarily through its flagship product, the Epione® robotic platform. This state-of-the-art technology is designed to enhance the planning, targeting, delivery, and confirmation of tumor ablation procedures for inoperable tumors in the abdomen and lungs. The Epione® platform leverages advanced robotics and image fusion technology, enabling clinicians to precisely target challenging tumors. The device is CE marked for abdominal and lung indications and is FDA cleared for use in abdominal ablation, catering to hospitals and cancer treatment centers globally, particularly in Europe and the United States.In 2022, Quantum Surgical reported a revenue of EUR 1,244,043.30, while also facing an EBITDA loss of EUR 10,862,763.50 for the same year. The company's revenue is generated through the sale and deployment of its Epione® robotic systems, integrated into the workflows of medical institutions, which may include service contracts and training programs for clinicians.In March 2024, Quantum Surgical SAS raised EUR 30 million in venture debt funding from the European Investment Bank to accelerate the global commercialization of its Epione® platform for treating abdominal and lung cancers. The company is strategically focusing on expanding into new markets and geographic regions, aiming to enhance its presence in both Europe and the United States as it develops and launches new products related to cancer treatment.

## Funding rounds

- Series A, Aug 13, 2018, $6.8M — Ally Bridge Group, Lifetech Scientific (Shenzhen) Co., Ltd.

## Investors

- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series A
- Lifetech Scientific (Shenzhen) Co., Ltd. — Series A